October 7, 2024 3-5PM ET
Monday on The Robert Scott Bell Show:
Hour 1
Breaking: New Cochrane Review Finds Water Fluoridation Has Minimal Effect on Dental Health A new Cochrane Review reveals that adding fluoride to drinking water provides limited dental benefits,particularly when compared to its effectiveness decades ago. The review follows a recent federal court ruling in California that determined water fluoridation poses an “unreasonable risk” of reduced IQ in children, calling for regulation by the Environmental Protection Agency (EPA). The study reviewed 157 comparisons between communities with and without fluoridated water, concluding that water fluoridation leads to only a slight reduction in tooth decay, amounting to about a quarter of a cavity in children’s baby teeth. However, the researchers noted that this effect was observed with “low certainty.” The findings highlight that past studies from the 1970s showed greater benefits, with fluoride reducing cavities by one full tooth in children, but such results are no longer applicable given improvements in dental health and the widespread use of fluoride in other products like toothpaste. The review also questions the argument that water fluoridation helps reduce oral health disparities, suggesting that more contemporary approaches are necessary. Despite the review’s findings, public health organizations, such as the CDC and ADA, remain firm in their support for water fluoridation, citing its historical effectiveness in reducing cavities.
Mpox Vaccine’s Protection Wanes Within 1 Year; Boosters Needed New research reveals that antibodies from the mpox vaccine, previously known as monkeypox, diminish within six to twelve months, underscoring the need for booster shots to maintain immunity. The study, led by Dr. Ai-ris Yonekura Collier at Beth Israel Deaconess Medical Center, involved monitoring 45 individuals who were either vaccinated or had a confirmed mpox diagnosis during the 2022 outbreak. Researchers tracked immune responses over 12 months, comparing the effectiveness of one or two doses of the Jynneos mpox vaccine. Results showed that vaccine-generated protection waned significantly over time, leaving at-risk groups vulnerable without a booster. The 2022 outbreak marked the first time mpox spread internationally, primarily affecting men who have sex with men, healthcare workers, and those who traveled to affected regions. As of September 2024, the WHO reported over 5,000 confirmed cases and 617 deaths in 14 African countries due to a more severe strain of mpox in the Democratic Republic of Congo. Researchers emphasize the importance of completing the recommended two-dose vaccine series and advocate for broader access to boosters to combat the ongoing outbreak. The study calls for larger human trials to further assess the vaccine’s long-term effectiveness.
WHO approves first mpox diagnostic test for emergency use, boosting global access The World Health Organization (WHO) has approved the first mpox (formerly known as monkeypox) diagnostic test foremergency use under its Emergency Use Listing (EUL) procedure. The Alinity m MPXV assay, developed by Abbott Molecular Inc., will help expand diagnostic capacity in regions heavily impacted by mpox outbreaks, such as Africa, where over 30,000 suspected cases have been reported in 2024 alone. The new test, which uses real-time PCR technology to detect mpox DNA from skin lesion swabs, will aid in early diagnosis, ensuring timely treatment and virus containment. Limited testing capacities have contributed to the virus’s continued spread, especially in countries like the Democratic Republic of the Congo, where only 37% of suspected cases have been tested. WHO’s EUL process expedites the availability of essential medical products during public health emergencies, and the listing of the Alinity m MPXV assay is seen as a critical step in improving global access to mpox testing. WHO has also received additional submissions from other manufacturers, aiming to broaden the range of quality-assured diagnostic tools for global procurement.
Brain scans reveal unique ‘fingerprints’ in every case of Alzheimer’s disease Researchers from University College London and Radboud University have found that Alzheimer’s disease affects the brain in a unique way for each person, comparable to a fingerprint. In a study involving more than 3,200 MRI brain scans of individuals with mild cognitive impairment or Alzheimer’s, and nearly 59,000 scans from healthy individuals, the researchers discovered that no two cases of brain shrinkage followed the same pattern. This method of identifying “brain fingerprints” tracks the shrinking of specific brain regions over time, providing a more personalized understanding of how the disease progresses in each individual. The study also found that those who had mild cognitive impairment but later developed dementia showed faster accumulation of brain abnormalities, which correlated with poorer cognitive performance. These findings suggest that this new approach could help predict the onset of Alzheimer’s earlier and tailor treatments to the individual. However, the study primarily involved individuals of European ancestry, and further research is needed across more diverse populations to validate the technique’s wider applicability. This breakthrough offers new hope for more personalized and effective treatment strategies for Alzheimer’s patients.
Welcome back to another episode of “Homeopathic Hits” on The Robert Scott Bell Show.
Today, we’re spotlighting Allium Cepa, a homeopathic remedy well-known for its effectiveness in treating colds, hay fever, and watery eyes.
Allium Cepa offers a natural approach to relieving the common symptoms of respiratory allergies and viral infections.
Download the Information Sheet
Hour 2
T
he Biggest Drug Fraud in History Ozempic, originally a diabetes drug, has become widely popular for weight loss, but experts warn it may be part of a massive drug fraud. The rise of drugs like Ozempic, whichstimulate feelings of fullness to help with weight loss, does not address the root cause of obesity, which is driven largely by the consumption of ultra-processed foods. These foods, designed to be addictive, subvert the body’s natural satiety mechanisms. Experts, such as Dr. Casey Means, argue that the obesity epidemic is tied to these toxic food environments rather than the absence of weight loss medications. The Treat and Reduce Obesity Act could expand government coverage for obesity drugs to 74% of Americans, which could cost over $3 trillion annually, without addressing the underlying health issues. Ozempic’s side effects include muscle loss, suicidal thoughts, cancer risks, and stomach paralysis. Despite these concerns, pharmaceutical companies, including Novo Nordisk, are heavily lobbying to expand the market for these drugs, pushing for them to be prescribed to children as young as six. Experts advocate for alternatives like improving diet and gut health rather than relying on long-term pharmaceutical interventions that fail to tackle the core issue of obesity.
Special Guest Mark Hilton
Mark Hilton, president and CEO of Alpine Gold, comes to the precious metals market from a varied career in high-technology marketing and business management. Mr. Hilton holds Master’s degrees in engineering and business from the University of California at Berkeley.
California Crews Begin Mowing Down Region’s Iconic Joshua Trees for Solar Farm Despite the Western Joshua Tree Conservation Act, California crews have started clearing thousands of iconic Joshuatrees to make way for the Aratina Solar Center in Kern County. The solar project, backed by the Newsom administration, aims to help California meet its climate goals by transitioning to renewable energy sources. However, this development has sparked outrage among local residents and environmental groups who argue that the destruction of these ancient trees undermines conservation efforts and poses long-term environmental risks. A local petition opposing the project has gathered over 52,000 signatures, with critics pointing out that these trees provide crucial habitats for numerous species and contribute to the region’s biodiversity. Moreover, residents fear that the construction activities, including land leveling and heavy equipment use, will increase the risk of valley fever—a fungal infection spread through dust. Despite the protests, the Kern County Board of Supervisors approved the project, which will span five sites, leading to concerns that the push for green energy is coming at the cost of significant ecological damage, with limited gains in sustainable energy.
Remember Friends, The Power to Heal is Yours!
